TALASAZ AMIRALI (Chairman, President and COO) sold 10.0% of their position (210K shares) of GUARDANT HEALTH, INC. on the open market
Open‑market sale worth $23.08M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
−200.00
Price / share
$100.95
Trade value
$20.19K
% of position
Common Stock
Shares
−900.00
Price / share
$102.57
Trade value
$92.31K
% of position
Common Stock
Shares
−1.37K
Price / share
$103.82
Trade value
$141.82K
% of position
Common Stock
Shares
−11.92K
Price / share
$105.01
Trade value
$1.25M
% of position
Common Stock
Shares
−1.20K
Price / share
$105.88
Trade value
$127.05K
% of position
Common Stock
Shares
−21.17K
Price / share
$106.99
Trade value
$2.27M
% of position
Common Stock
Shares
−33.07K
Price / share
$108.11
Trade value
$3.57M
% of position
Common Stock
Shares
−9.85K
Price / share
$108.97
Trade value
$1.07M
% of position
Common Stock
Shares
−28.91K
Price / share
$110.10
Trade value
$3.18M
% of position
Common Stock
Shares
−37.16K
Price / share
$111.14
Trade value
$4.13M
% of position
Common Stock
Shares
−37.90K
Price / share
$112.02
Trade value
$4.25M
% of position
Common Stock
Shares
−26.35K
Price / share
$112.76
Trade value
$2.97M
% of position
Net shares
−210K
Net value
-$23.08M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/20/2026 | S · Sale | −200.00 | $100.95 | $20.19K | 0.0% | 2.10M | 2.10M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −900.00 | $102.57 | $92.31K | 0.0% | 2.10M | 2.10M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −1.37K | $103.82 | $141.82K | 0.1% | 2.10M | 2.09M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −11.92K | $105.01 | $1.25M | 0.6% | 2.09M | 2.08M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −1.20K | $105.88 | $127.05K | 0.1% | 2.08M | 2.08M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −21.17K | $106.99 | $2.27M | 1.0% | 2.08M | 2.06M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −33.07K | $108.11 | $3.57M | 1.6% | 2.06M | 2.03M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −9.85K | $108.97 | $1.07M | 0.5% | 2.03M | 2.02M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −28.91K | $110.10 | $3.18M | 1.4% | 2.02M | 1.99M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −37.16K | $111.14 | $4.13M | 1.9% | 1.99M | 1.95M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −37.90K | $112.02 | $4.25M | 1.9% | 1.95M | 1.91M |
| Common Stock Indirect | 5/20/2026 | S · Sale | −26.35K | $112.76 | $2.97M | 1.4% | 1.91M | 1.89M |
| Total | −210K | -$23.08M | ||||||